NYSE:OPK
Opko Health Inc Stock News
$1.25
-0.0500 (-3.85%)
At Close: May 08, 2024
Pfizer's (PFE), OPKO's BLA for Somatrogon Gets CRL From FDA
05:48pm, Monday, 24'th Jan 2022 Zacks Investment Research
The FDA issues a Complete Response Letter to Pfizer (PFE) and OPKO Health's biologics license application for somatrogon to treat growth hormone deficiency in pediatric patients.
G Medical, Reviva top healthcare gainers; OPKO Health, AnPac Bio-Medical among losers
03:02pm, Monday, 24'th Jan 2022 Seeking Alpha
G Medical Innovations (GMVD) +18%. Reviva Pharmaceuticals (RVPH) +14%. OPKO Health (OPK) -20%. AnPac Bio-Medical Science (ANPC) -18%.
Why Opko Health Stock Is Off 23% Today
02:06pm, Monday, 24'th Jan 2022
The market was counting on a key drug approval that suddenly appears unlikely to happen.
Pfizer's (PFE), OPKO's BLA for Somatrogon Gets CRL From FDA
01:53pm, Monday, 24'th Jan 2022
The FDA issues a Complete Response Letter to Pfizer (PFE) and OPKO Health's biologics license application for somatrogon to treat growth hormone deficiency in pediatric patients.
Coinbase Global, MicroStrategy, OPKO Health among premarket losers'' pack
01:48pm, Monday, 24'th Jan 2022 Seeking Alpha
ReTo Eco-Solutions (RETO) -39%.OneSmart International Education (ONE) -33%.Pintec Technology (PT) -23%.Digital World Acquisition (DWACW) -21%.Bon Natural Life (BON) -19%.Blue Star…
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
11:11am, Monday, 24'th Jan 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled 450 points in the previous session. Investors are awaiting earnings results from Halliburton Comp
Pfizer - OPKO Health''s Growth Hormone Deficiency Candidate Receives FDA Response Letter
10:49am, Monday, 24'th Jan 2022 Benzinga
The FDA has issued a Complete Response Letter (CRL) to Pfizer Inc (NYSE: PFE ) and OPKO Health Inc''s (NASDAQ: OPK ) somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for pediatric growth hormone deficiency (GHD). Pfizer is evaluating the FDA''s comments. Earlier this week, Japan''s Ministry of Health, Labour, and Welfare
Pfizer, Opko Shares Fall After FDA Declines to Approve Somatrogon
07:27am, Monday, 24'th Jan 2022
Pfizer said it is evaluating the FDA's comments and will work with the agency "to determine an appropriate path forward."
OPKO's (OPK) NGENLA Approved by Japan's MHLW for GHD Treatment
02:16pm, Friday, 21'st Jan 2022 Zacks Investment Research
Latest approval for OPKO's (OPK) NGENLA is expected to reduce the treatment frequency from daily injections, thereby better serving the GHD patient pool.
OPKO's (OPK) NGENLA Approved by Japan's MHLW for GHD Treatment
10:49am, Friday, 21'st Jan 2022
Latest approval for OPKO's (OPK) NGENLA is expected to reduce the treatment frequency from daily injections, thereby better serving the GHD patient pool.
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
02:39pm, Tuesday, 18'th Jan 2022 Benzinga
Sema4 Holdings Corp (NASDAQ: SMFR ) has agreed to acquire OPKO Health Inc''s (NASDAQ: OPK ) wholly-owned subsidiary, GeneDx Inc , for approximately $623 million. Sema4 will acquire GeneDx for an upfront payment of $150 million in cash plus 80 million shares in Sema4, with up to an additional $150 million revenue-based milestones over the next two years. Together, Sema4 and GeneDx will be one of the largest providers of genomic clinical Full story available on Benzinga.com
Sema4 agrees to acquire OPKO Health''s GeneDx in ~$623M deal
02:25pm, Tuesday, 18'th Jan 2022 Seeking Alpha
Sema4 (SMFR) has agreed to acquire OPKO Health''s (OPK) wholly-owned subsidiary, GeneDx.Sema4 will make an upfront cash payment of $150M plus 80M in Sema4 shares
Stock Market News for Today, January 18th, 2022
02:09pm, Tuesday, 18'th Jan 2022 PennyStocks
What to watch with penny stocks today
The post Stock Market News for Today, January 18th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference
09:05pm, Wednesday, 05'th Jan 2022 Kwhen Finance
Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out
04:30pm, Sunday, 02'nd Jan 2022 PennyStocks
Add these three penny stocks to your January 2022 watchlist
The post Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out appeared first on Penny Stocks to Buy, Picks, News and Informatio
